Itroza 100 Capsule contains Itraconazole 100 mg, a broad-spectrum triazole antifungal agent effective against a wide range of fungal infections. Itroza 100 is indicated for the treatment of systemic and superficial mycoses, including blastomycosis, histoplasmosis, aspergillosis, onychomycosis, and various forms of candidiasis. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The capsule formulation ensures optimal bioavailability when administered orally, with absorption enhanced by gastric acidity. Itroza 100 should be taken with food to maximize absorption. Dosage and duration of therapy depend on the type and severity of the infection, and treatment should be guided by clinical response and laboratory findings. Caution is advised in patients with hepatic impairment, congestive heart failure, or those taking concomitant medications metabolized by the cytochrome P450 system, as itraconazole may cause drug interactions. Common adverse effects include gastrointestinal disturbances, headache, and elevated liver enzymes. Regular monitoring of liver function tests is recommended during prolonged therapy. Itroza 100 Capsule should be prescribed and used under medical supervision to ensure safety and efficacy.